Retroviral integration was assumed to be a random process, and consequently, retroviruses have been considered safe gene delivery vehicles for use in gene therapy. However, recent reports of leukemia in two of 11 children treated for a rare blood disease with a murine leukemia virus (MLV) –based gene therapy vector questioned the random nature of retroviral integration. In the June 13
Wu et al. mapped 903 MLV and 379 human immunodeficiency virus–1 (HIV-1) integrations in the human genome. They observed that MLV preferred integration near the start of transcriptional units, either upstream or downstream. However, HIV-1 preferred integration anywhere in the transcriptional unit but not upstream of the transcriptional start.
"That both viruses favor expressed genes is...